shutterstock-73668832-1-
16 October 2013AmericasJose Trigueros

Room for improvement: enforcing data exclusivity provisions in Mexico

Data exclusivity is usually discussed in academic circles, mainly due to enforcement complexities and when cases are brought against the Federal Commission for the Protection against Sanitary Risks, the government branch in charge of issuing of marketing authorisations for drugs and agrichemicals.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
30 June 2026   Sandoz has filed FDA applications for generic versions of Eli Lilly’s blockbuster drugs, marking an early step towards potential competition in the fast-growing GLP-1 market.
Americas
25 June 2026   The Federal Circuit has brought Paxlovid’s infringement case to an end, serving as a reminder that even minor changes to patent language can have major consequences.
Americas
17 June 2026   A cancer diagnostics company has lost its bid to overturn a jury verdict in a major patent dispute that has also spawned parallel proceedings before the Federal Circuit and PTAB.